AbbVie Inc. said it’s not in talks to acquire the cancer-focused biotech company Revolution Medicines Inc.
“AbbVie is not in discussions with RevMed,” a spokesperson for AbbVie said in a statement to Bloomberg News.
AbbVie Inc. said it’s not in talks to acquire the cancer-focused biotech company Revolution Medicines Inc.
“AbbVie is not in discussions with RevMed,” a spokesperson for AbbVie said in a statement to Bloomberg News.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.